LAMEA Defibrillators Market By Product Type (Advanced Life Support Defibrillators, Automated External Defibrillators, Implantable Cardioverter - Transvenous Implantable Cardioverter Defibrillator, Subcutaneous Implantable Cardioverter Defibrillator; Wearable Defibrillators), End Use (Hospital, Pre-Hospital, Public Access Market, Alternate Care Market, Home Healthcare)
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The LAMEA defibrillators market has a potential to reach $ 2,847.8 million by 2022. The defibrillation procedure is used to deliver an electric shock to the heart, depolarizing the heart muscles and restoring the heart to its normal electric impulse. Growing interest in public access defibrillator (PAD) by the public & private organizations has led the market to witness unprecedented growth. The report highlights the adoption of Defibrillators in LAMEA region. Based on the product type; the Defibrillators market is segmented into Advanced Life Support (ALS) Defibrillators, Automated External Defibrillators (AEDs), Implantable Cardioverter Defibrillators (ICD), Wearable Defibrillators market.
Further the Implantable Cardioverter Defibrillators (ICD) segment is sub segmented into Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs) market. Based on the end use avenue, the market is bifurcated into Hospitals, Pre-hospitals, Public Access Markets, Alternate Care Markets, Home Healthcare market. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA.
The report provides a comprehensive analysis of the key players operating in the world defibrillators market, such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.